ProofPilot is adding new features and functionalities to its platform for designing, deploying and managing research studies, with the goal to make it easier to create or replicate randomized, controlled trials.
ProofPilot now has the “Study Template” feature which reduces the barriers for those outside pharma and academia to run scientifically valid studies that answer key questions about what works to improve the human condition.
“We kept hearing from all sorts of different people, ‘no one will run this a study on my question, or these results are from far away and aren’t applicable to my community,” Matthew Amsden, CEO at ProofPilot, said in a statement. “People want to run studies on digital health devices, fitness regimes, dietary changes, alternative wellness efforts, social service programs… they are frustrated that they can’t point to research studies that prove the efficacy of these tools within the varied communities that make up our society.”
Study Templates allow users to choose from an initial batch of 10 templates based on previously completed scientifically valid efforts and quickly tailor them for their own research questions and launch to participants. The feature combines research replication with a concept called Community Based Participatory Research or CBPR. Organizations and institutions closer to the interests of potential participants tailor the templates to make them more relevant and engaging.
All regulatory and ethical review of studies will automatically be conducted by Veritas IRB of Montreal. This ensures studies run outside traditional pharma and academic settings are conducted in accordance to the highest ethical standards.
Earlier this month, ProofPilot has launched with traditional customers like NYU’s Langone Medical Center and Columbia University’s Lyme and Tick-Borne Diseases Research Center and finished up major studies with University of Kentucky.